Diagnostics channel feed – Endpoints News

SIGN UP

Diagnostics channel feed

Stephen Hahn’s liquid biopsy company Harbinger Health raises $140M Series B to launch first cancer tests by 2025

2 days ago

Element Biosciences logs 100 DNA sequencer orders as it gains momentum in a competitive market

4 weeks ago

Illumina began hunt for CEO candidates in midst of activist fight, eventually picking little-known diagnostics exec

4 weeks ago

Illumina names former Agilent exec as CEO, months after parting ways with deSouza

4 weeks ago

PacBio, once slated to be acquired by Illumina, is taking on the DNA giant

Last month

His tiny prenatal testing company has big plans after exacting legal revenge on lab giants

Last month

Diagnostics outfit lays off third of employees, now looking at 'strategic alternatives'

4 months ago

FDA warns some Illumina DNA sequencing devices could be vulnerable to hackers

5 months ago

Quest Diagnostics buys Bert Vogelstein’s Haystack Oncology, just six months after Series A

5 months ago

Pattern Bioscience raises $28.7M Series C for faster, more efficient antibiotic resistance test

5 months ago

As showdown with activist nears, Illumina’s CEO defends the company’s $7.1B purchase of Grail

5 months ago

Ex-US Commerce Secretary Wilbur Ross pairs his SPAC with Alzheimer's biotech

8 months ago

Qiagen picks up DNA forensics company for $150M

8 months ago

Thermo Fisher wagers on early cancer diagnostics in $2.6B cash deal for multiple myeloma test maker

11 months ago

After blocking Grail acquisition, EU leaves Illumina with few good options

Last year

China's DNA giant confronts skepticism in US expansion bid

Last year

Korean diagnostics biotech goes transpacific, agreeing to shell out $1.5B to take Meridian private

Last year

As new monkeypox cases spike globally, Labcorp rolls out first national lab test

Last year

Roche's ROS1+ cancer drug gets FDA greenlight for Foundation Medicine's companion diagnostic

Last year

Precision drug + diagnostics biotech scores modest Series A, retrofitting existing drug for new indication

Last year

Bay Area genomics startup emerges from stealth with $600M in the bank and promising a '$100 genome' test

Last year

Guardant Health fires back at Illumina suit, claiming retaliation over its role in FTC antitrust investigation

Last year

Roche unveils three new monkeypox tests as cases rise

Last year

Can OncoHost's PROphet predict host response to cancer treatments? Investors are waiting to find out

Last year

12 Next page Last page